Literature DB >> 27288881

Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa.

Anna Trzeciecka1, J Jussi Paterno2, Elisa Toropainen3, Ali Koskela1, Lucia Podracka3, Eveliina Korhonen4, Anu Kauppinen5, Kai Kaarniranta6, Adrian Smedowski7.   

Abstract

Success of the long-term glaucoma therapy and preservation of the visual function strongly depend on patients' compliance which may be affected by the inconvenience of treatment and its side effects. Recently, introduction of preservative-free anti-glaucoma agents has become an important step towards improved glaucoma care by eliminating the negative effects of preservatives on the eye surface. Although, newly developed eye drop formulations do not contain standard preservatives, they still can be harmful to ocular surface due to other excipients. In this study, we compared tolerability of commercial preservative-free (pf) prostaglandin analogues (pf tafluprost, pf latanoprost and pf bimatoprost) in long-term topical application in rabbits in vivo. We found that after eight weeks treatment, pf latanoprost was the worst tolerated among the tested drops. It expressed increased conjunctival redness and blinking frequency. Furthermore, it caused increased LDH release in the aqueous humour, infiltration of macrophages in the eyelids and visible defects in conjunctival goblet cells. However, we did not detect increased levels of inflammatory markers in the tear fluid or in the aqueous humour. Based on our study, we suspect that these negative effects are related to excipients included in pf latanoprost formulation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Macrophages; Preservative-free prostaglandin analogues; Tolerability; Topical application

Mesh:

Substances:

Year:  2016        PMID: 27288881     DOI: 10.1016/j.ejphar.2016.06.014

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  A new scale for the assessment of conjunctival bulbar redness.

Authors:  Ilaria Macchi; Vatinee Y Bunya; Mina Massaro-Giordano; Richard A Stone; Maureen G Maguire; Yuanjie Zheng; Min Chen; James Gee; Eli Smith; Ebenezer Daniel
Journal:  Ocul Surf       Date:  2018-06-06       Impact factor: 5.033

2.  Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.

Authors:  Francesco Oddone; Vincenzo Scorcia; Michele Iester; Dario Sisto; Stefano De Cilla; Paolo Bettin; Carlo Cagini; Michele Figus; Giorgio Marchini; Luca Rossetti; Gemma Rossi; Tommaso Salgarello; Gian Luca Scuderi; Giovanni Staurenghi
Journal:  Clin Ophthalmol       Date:  2022-06-01

Review 3.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

Review 4.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

Review 5.  Systemic side effects of eye drops: a pharmacokinetic perspective.

Authors:  Andre Farkouh; Peter Frigo; Martin Czejka
Journal:  Clin Ophthalmol       Date:  2016-12-07

6.  FluoroGold-Labeled Organotypic Retinal Explant Culture for Neurotoxicity Screening Studies.

Authors:  Adrian Smedowski; Marita Pietrucha-Dutczak; Ruchi Maniar; Michael Ajeleti; Iwona Matuszek; Joanna Lewin-Kowalik
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

Review 7.  Preservatives in glaucoma medication.

Authors:  David W Steven; Pouya Alaghband; Kin Sheng Lim
Journal:  Br J Ophthalmol       Date:  2018-07-04       Impact factor: 4.638

8.  SCD1-Fatty Acid Desaturase Inhibitor MF-438 Alleviates Latent Inflammation Induced by Preservative-Free Prostaglandin Analog Eye Drops.

Authors:  Anna Pacwa; Joanna Machowicz; Alicja Wojtyniak; Marita Pietrucha-Dutczak; Elisa Toropainen; Ali Koskela; Ewa Mrukwa-Kominek; Joanna Lewin-Kowalik; Adrian Smedowski
Journal:  J Inflamm Res       Date:  2022-02-08

9.  Clinical Outcomes in Maximum Tolerated Medical Therapy in Penetrating Keratoplasty for Bullous Keratopathy.

Authors:  Seoyoung Wy; Young Kook Kim; Jin Wook Jeoung; Mee Kum Kim
Journal:  Front Med (Lausanne)       Date:  2022-03-01

10.  The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations.

Authors:  Ruiz Simonato Alonso; Helena Parente Solari; Eduardo de França Damasceno; Miguel Noel Nascentes Burnier; Marcelo Palis Ventura
Journal:  BMC Pharmacol Toxicol       Date:  2020-03-23       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.